Melissa Suma and Haibo Zhang*
Epidemiological data from the COVID-19 pandemic shows increased severity and mortality among males compared with females. Several studies offer evidence that this disparity may be, in part, due to sex hormone biases contributing to different outcomes in SARS-CoV-2, suggesting hormone therapy as a potential combination treatment alongside antivirals in COVID-19. This review explores the potential mechanisms by which estrogen and androgen have distinct impacts on the development of COVID-19.
HTML PDFShare this article
Clinical and Medical Case Reports received 40 citations as per Google Scholar report
